Characterization of an Ig VH idiotope that results in specific homophilic binding and increased avidity for antigen
- PMID: 8759742
Characterization of an Ig VH idiotope that results in specific homophilic binding and increased avidity for antigen
Abstract
mAb against GD3 ganglioside demonstrate homophilic binding in which soluble anti-GD3 mAb bind, through the GD3 binding site, to a VH idiotope (designated IdHOM) on solid phase anti-GD3 mAb. In this way, homophilic binding provides a mechanism for amplifying the binding of mAb to cell surface GD3. We show that serine 52a, within CDR2, is required for IdHOM expression, homophilic binding, and high avidity binding to cell surface GD3. Computer modeling based on the crystal structure of anti-GD3 mAb R24 showed serine 52a situated at the mouth of the GD3 binding pocket, but not directly involved with GD3 binding. Substitutions at position 52a predicted to maintain the GD3 binding pocket (e.g., threonine) resulted in the loss of IdHOM expression and homophilic binding and markedly decreased binding to cell surface GD3, but maintained low avidity GD3 binding as measured by ELISA. All other substitutions at position 52a were predicted to significantly distort the GD3 binding pocket and resulted in the loss of both homophilic binding and any detectable avidity for GD3. We have structurally defined IdHOM and conclude that this idiotope is not required for the GD3 binding pocket, but that the idiotope is necessary for homophilic binding, which is required for high avidity binding to cell surface GD3. We speculate that selection of certain VH genes may result in the expression of idiotopes that allow homophilic binding, and this may represent a general mechanism for increasing the avidity of Abs against T cell-independent Ags.
Similar articles
-
Homophilic binding of mouse monoclonal antibodies against GD3 ganglioside.J Immunol. 1990 Aug 1;145(3):891-8. J Immunol. 1990. PMID: 1695649
-
The role of homophilic binding in anti-tumor antibody R24 recognition of molecular surfaces. Demonstration of an intermolecular beta-sheet interaction between vh domains.J Biol Chem. 1999 Feb 26;274(9):5597-604. doi: 10.1074/jbc.274.9.5597. J Biol Chem. 1999. PMID: 10026176
-
VH-related idiotopes detected by site-directed mutagenesis. A study induced by the failure to find CD4 anti-idiotypic antibodies mimicking the cellular receptor of HIV.J Immunol. 1992 Aug 15;149(4):1237-41. J Immunol. 1992. PMID: 1500715
-
Comparison of the three-dimensional structures of a humanized and a chimeric Fab of an anti-gamma-interferon antibody.J Mol Recognit. 1999 Jan-Feb;12(1):19-32. doi: 10.1002/(SICI)1099-1352(199901/02)12:1<19::AID-JMR445>3.0.CO;2-Y. J Mol Recognit. 1999. PMID: 10398393 Review.
-
Kinetic analysis of engineered antibody-antigen interactions.J Mol Recognit. 1994 Mar;7(1):1-7. doi: 10.1002/jmr.300070102. J Mol Recognit. 1994. PMID: 7527233 Review.
Cited by
-
Cross-presentation of disialoganglioside GD3 to natural killer T cells.J Exp Med. 2003 Jul 7;198(1):173-81. doi: 10.1084/jem.20030446. J Exp Med. 2003. PMID: 12847141 Free PMC article.
-
Endowing self-binding feature restores the activities of a loss-of-function chimerized anti-GM2 antibody.Cancer Immunol Immunother. 2007 Feb;56(2):147-54. doi: 10.1007/s00262-006-0182-2. Epub 2006 Aug 3. Cancer Immunol Immunother. 2007. PMID: 16896968 Free PMC article.
-
Development of a novel therapy for Lipo-oligosaccharide-induced experimental neuritis: use of peptide glycomimics.J Neurochem. 2010 Apr;113(2):351-62. doi: 10.1111/j.1471-4159.2010.06627.x. Epub 2010 Feb 1. J Neurochem. 2010. PMID: 20132479 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources